Form 4: CVRx Director Joseph Slattery Receives Significant Stock Option Grant
Insider Transaction Report
CVRx, Inc. Director Joseph P. Slattery was granted 19,554 stock options with an exercise price of $6.76, aligning his interests with long-term shareholder value.
Summary
- Joseph P. Slattery, a Director of CVRx, Inc. (CVRX), was granted 19,554 stock options.
- The stock options have an exercise price of $6.76 per share.
- These options are exercisable for 19,554 shares of CVRx, Inc. Common Stock.
- The options are set to expire on June 3, 2035.
- The options will vest on the earlier of June 3, 2026, or the Issuer's 2026 annual meeting of stockholders.
Sentiment
Score: 7
Explanation: The grant of stock options to a director is generally viewed positively as it aligns the director's incentives with shareholder interests and is a standard practice in corporate governance.
Positives
- The grant of stock options aligns the director's financial interests with the long-term performance and shareholder value creation of CVRx, Inc.
- The exercise price of $6.76 provides a clear incentive for the director to contribute to the company's stock price appreciation above this level.
Future Outlook
The vesting schedule for the granted options indicates a future commitment and incentive for the director, aligning their interests with the company's performance through at least mid-2026.
Industry Context
This transaction represents a routine equity compensation grant to a director, which is a common practice across various industries to incentivize leadership and align their interests with shareholder value. It does not indicate broader industry-specific trends or shifts.
Related Party Transactions
- The stock option grant to Joseph P. Slattery, a Director of CVRx, Inc., constitutes a related party transaction as it involves compensation provided to an insider of the company.
Stakeholder Impact
- Shareholders: The grant aims to align the director's interests with those of shareholders by incentivizing efforts that lead to stock price appreciation.
Next Steps
- The stock options will vest on the earlier of June 3, 2026, or the Issuer's 2026 annual meeting of stockholders.
- The director may exercise the vested options at any time before their expiration date of June 3, 2035.
Key Dates
| Date | Description |
|---|---|
| 06/03/2025 | Date of the stock option grant transaction. |
| 06/05/2025 | Date the Form 4 filing was signed by Amy C. Seidel, Attorney-in-Fact. |
| 06/03/2026 | Earliest date the granted stock options will vest. |
| 06/03/2035 | Expiration date of the granted stock options. |
Keywords
CVRx Inc., CVRX, Stock Option Grant, Director Compensation, Insider Transaction, Form 4, Equity Compensation, Joseph P. Slattery
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.